glp 1 medications pros and cons of drugs what are the different glp-1 drugs Do The Benefits of GLP-1 Drugs OutWeigh the GLP-1 diabetes and weight-loss drug

However, it is important to note that type 2 diabetes, obesity, and metabolic dysfunction may specifically increase the likelihood of developing HFpEF more than HF with reduced ejection fraction (HFrEF) (Samson et al., 2016)

Obesity is a central component of metabolic syndrome and a major risk factor for hypertension, dyslipidemia, and insulin resistance

Side effects are uncommon but possible, which is why REVIV conducts medical screenings prior to treatment

Expect internal benefits in the first month, with external results emerging from the second month

Are GLP-1s worth the investment for employers knowing that employees may leave before the long-term health and cost benefits are realized